Presynaptic Dopaminergic Deficits in Lesch–Nyhan Disease
Open Access
- 13 June 1996
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (24), 1568-1572
- https://doi.org/10.1056/nejm199606133342403
Abstract
Lesch–Nyhan disease is a rare, devastating, X-linked recessive disorder of purine synthesis. Patients present with hyperuricemia, choreoathetosis, dystonia, and aggressive and self-injurious behavior. Although the genetic and biochemical abnormalities have been identified, the causes of the neuropsychiatric syndrome remain unclear. We used positron-emission tomography to measure presynaptic accumulation of fluorodopa F 18 tracer in the dopaminergic regions of the brains of 12 patients with Lesch–Nyhan disease (age, 10 to 20 years) and 15 healthy controls (age, 12 to 23). The results were expressed as ratios of specific to nonspecific radioactive counts. A low ratio indicates decreased dopa decarboxylase activity and dopamine storage. The fluorodopa F 18 ratio was significantly lower in the putamen (31 percent of control values), caudate nucleus (39 percent), frontal cortex (44 percent), and ventral tegmental complex (substantia nigra and ventral tegmentum; 57 percent) in the patients with Lesch–Nyhan disease than in the controls. Uptake of the tracer was abnormally low even in the youngest patients tested, and there was no overlap in the values between patients and controls. Patients with Lesch–Nyhan disease have abnormally few dopaminergic nerve terminals and cell bodies. The abnormality involves all dopaminergic pathways and is not restricted to the basal ganglia. These dopaminergic deficits are pervasive and appear to be developmental in origin, which suggests that they contribute to the characteristic neuropsychiatric manifestations of the disease.Keywords
This publication has 25 references indexed in Scilit:
- Development of Dopaminergic Neurons in the Human Mesencephalon and in Vitro Effects of Basic Fibroblast Growth Factor TreatmentExperimental Neurology, 1994
- Positron emission tomography with 18F-DOPA: Interpretation and biological correlates in nonhuman primatesPsychiatry Research: Neuroimaging, 1992
- Cognitive abilities of patients with Lesch-Nyhan diseaseJournal of Autism and Developmental Disorders, 1992
- New rapid analysis method demonstrates differences in 6-[18F]fluoro-l-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeysInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
- Development of dopaminergic neurons in the human substantia nigraExperimental Neurology, 1991
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- Monoamine deficiency in a transgenic (Hprt−) mouse model of Lesch-Nyhan syndromeBrain Research, 1989
- Determination of plasma [18F]-6-fluorodopa during positron emission tomography: Elimination and metabolism in carbidopa treated subjectsLife Sciences, 1986
- DOPAMINERGIC RECEPTOR SUPERSENSITIVITY IN SELF-MUTILATORY BEHAVIOUR OF LESCH-NYHAN DISEASEThe Lancet, 1985
- Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch-Nyhan SyndromeNew England Journal of Medicine, 1981